These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 6218111
1. [Pharmacokinetics and dosage of mezlocillin administered by intravenous infusion]. Modr Z, Dvorácek K, Janků I, Krebs V. Infection; 1982; 10 Suppl 3():S191-5. PubMed ID: 6218111 [Abstract] [Full Text] [Related]
2. Kinetics of mezlocillin and carbenicillin. Pancoast SJ, Neu HC. Clin Pharmacol Ther; 1978 Jul; 24(1):108-16. PubMed ID: 657712 [Abstract] [Full Text] [Related]
3. [Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies]. Modr Z, Dvorácek K, Janků I, Krebs V. Infection; 1982 Jul; 10 Suppl 3():S184-90. PubMed ID: 7152688 [Abstract] [Full Text] [Related]
4. Nonlinear mezlocillin kinetics due to dose-dependent metabolism. Gundert-Remy U, Hildebrandt R, Stiehl A, Weber E. Clin Pharmacol Ther; 1983 May; 33(5):656-62. PubMed ID: 6220858 [Abstract] [Full Text] [Related]
5. Comparison between the pharmacokinetic properties of mezlocillin when given intravenously as a bolus injection or as an infusion. Ohlsson H, Bergan T. Arzneimittelforschung; 1979 May; 29(12a):1958-9. PubMed ID: 543900 [Abstract] [Full Text] [Related]
6. [Penetration of mezlocillin and oxacillin into the glandular and adipose tissue of the breast after simultaneous intravenous infusion. A pharmacokinetic study]. Bordt J, Holzgreve W, Wagner H, Adam D. Geburtshilfe Frauenheilkd; 1983 Jan; 43(1):18-9. PubMed ID: 6219911 [Abstract] [Full Text] [Related]
9. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)]. Brogard JM, Comte F, Kopferschmitt J, Dorner M, Lavillaureix. Nouv Presse Med; 1982 Feb 04; 11(5 Pt 2):340-6. PubMed ID: 6460973 [Abstract] [Full Text] [Related]
10. [Pharmacokinetics of intravenous mezlocillin in patients with normal and impaired renal function (author's transl)]. Cano JP, Rigault JP, Gevaudan MJ, Saingra S, Murisasco A, Charpin J. Nouv Presse Med; 1982 Feb 04; 11(5 Pt 2):335-9. PubMed ID: 6460972 [Abstract] [Full Text] [Related]
11. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin. Bergan T, Thorsteinsson SB, Steingrimsson O. Chemotherapy; 1982 Feb 04; 28(3):160-70. PubMed ID: 6212204 [Abstract] [Full Text] [Related]
12. Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function. Frimodt-Möller N, Maigaard S, Toothaker RD, Bundtzen RW, Brodey MV, Craig WA, Welling PG, Madsen PO. Antimicrob Agents Chemother; 1980 Apr 04; 17(4):599-607. PubMed ID: 6446877 [Abstract] [Full Text] [Related]
13. [Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)]. Lode H, Niestrath U, Koeppe P, Langmaack H. Infection; 1977 Apr 04; 5(3):163-9. PubMed ID: 334673 [Abstract] [Full Text] [Related]
16. Mezlocillin kinetics in hepatic insufficiency. Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FC. Clin Pharmacol Ther; 1983 Jan 04; 33(1):73-6. PubMed ID: 6217018 [Abstract] [Full Text] [Related]
17. [HPLC study of the pharmacokinetics of mezlocillin administered by 30-minute infusion and comparison with the direct intravenous route]. Jehl F, Peter JD, Monteil H, Dupeyron JP, Minck R. Pathol Biol (Paris); 1984 May 04; 32(5):312-7. PubMed ID: 6739140 [Abstract] [Full Text] [Related]
18. [Tissue concentrations of mezlocillin in prostate adenomas following intravenous bolus injections and continuous infusions]. Naber K, Adam D. Fortschr Med; 1983 Nov 03; 101(41):1862-8. PubMed ID: 6197351 [Abstract] [Full Text] [Related]
19. Kinetics of intravenous mezlocillin in chronic hemodialysis patients. Francke E, Mehta S, Neu HC, Appel GB. Clin Pharmacol Ther; 1979 Aug 03; 26(2):228-31. PubMed ID: 455891 [Abstract] [Full Text] [Related]
20. Pharmacokinetics of mezlocillin in patients with kidney impairment: special reference to hemodialysis and dosage adjustments in relation to renal function. Brogard JM, Comte F, Spach MO, Lavillaureix J. Chemotherapy; 1982 Aug 03; 28(5):318-26. PubMed ID: 6216076 [Abstract] [Full Text] [Related] Page: [Next] [New Search]